Integra LifeSciences Holdings Corporation (IART)
-NasdaqGS 36.51 
0.01(0.03%) 4:00PM EDT|After Hours
:
36.51 0.00 (0.00%) 4:37PM EDT
| Prev Close: | 36.50 |
|---|
| Open: | 35.96 |
|---|
| Bid: | N/A |
|---|
| Ask: | 42.00 x 100 |
|---|
| 1y Target Est: | 40.55 |
|---|
| Beta: | 0.9 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 35.93 - 36.81 |
|---|
| 52wk Range: | 30.87 - 44.53 |
|---|
| Volume: | 166,422 |
|---|
| Avg Vol (3m): | 230,617 |
|---|
| Market Cap: | 1.02B |
|---|
| P/E (ttm): | 34.09 |
|---|
| EPS (ttm): | 1.07 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- INTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Thu 9:16AM EDT)
- Medical Device Companies Trading at 7% Free Cash Flow Yield: Portfolio Manager Mark W. Oelschlager Discusses Investing in Overlooked AreasWall Street Transcript(Fri, May 17)
- INTEGRA LIFESCIENCES HOLDINGS CORP FinancialsEDGAR Online Financials(Fri, May 10)
- Disappointing 1Q Earnings for IARTZacks(Fri, May 10)
- Integra LifeSciences to Participate in Investor Conferences in MayGlobeNewswire(Tue, May 7)
- Integra LifeSciences Holdings Inc. Stock Downgraded (IART)at TheStreet(Mon, May 6)
- Investors are Digesting These Healthcare Stock Earnings Insightsat Wall St. Cheat Sheet(Sat, May 4)
- Integra LifeSciences Holdings Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 2)
- INTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, May 2)
- Integra LifeSciences Holdings Earnings: Here’s Why Investors are Buying Shares Nowat Wall St. Cheat Sheet(Thu, May 2)
- Q1 2013 Integra LifeSciences Corporation Earnings Release - Before Market OpenCCBN(Thu, May 2)
- Integra LifeSciences Reports First Quarter 2013 Financial ResultsGlobeNewswire(Thu, May 2)
- Integra Lifesciences Holdings Earnings Preview: Can This Streak Continue?at Wall St. Cheat Sheet(Wed, May 1)
- Integra LifeSciences Introduces Hollywood(TM) VI Spinal Fusion SystemGlobeNewswire(Tue, Apr 30)
- Integra LifeSciences Debuts Next-Generation Camino(R) Platform at 2013 American Association of Neurological Surgeons Annual MeetingGlobeNewswire(Mon, Apr 29)
Key Statistics
| Forward P/E (1 yr): | 11.45 |
|---|
| P/S (ttm): | 1.23 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.51 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.55 |
|---|
| Mean Recommendation*: | 2.4 |
|---|
| PEG Ratio (5 yr expected): | 1.26 |
|---|
Business Summary
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for neurosurgery, extremity reconstruction, orthopedics, and general surgery.
View More